Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
54.51
-0.19 (-0.35%)
At close: Aug 14, 2026, 4:00 PM EDT
53.55
-0.96 (-1.76%)
After-hours: Aug 14, 2026, 7:34 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $3.89 billion as of August 14, 2026. Its market cap has increased by 252.23% in one year.
Market Cap
3.89B
Enterprise Value
2.55B
1-Year Change
252.23%
Ranking
Category
Stock Price
$54.51
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $3.89B, an increase of 608.26%. That is a compound annual growth rate of 74.15%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 14, 2026 | 3.89B | -19.16% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Relay Therapeutics | 4.35B |
| Tango Therapeutics | 4.32B |
| Enliven Therapeutics | 4.31B |
| Telix Pharmaceuticals | 4.03B |
| Legend Biotech | 3.94B |
| Denali Therapeutics | 3.90B |
| Viking Therapeutics | 3.87B |
| Arcus Biosciences | 3.75B |